| 281 |
Involvement of glutamate, oxidative stress and inducible nitric oxide synthase in the
convulsant activity of ciprofloxacin in mice |
2012 |
| 282 |
Involvement of glutamate, oxidative stress and inducible nitric oxide synthase in the
convulsant activity of ciprofloxacin in mice |
2012 |
| 283 |
Involvement of glutamate, oxidative stress and inducible nitric oxide synthase in the
convulsant activity of ciprofloxacin in mice |
2012 |
| 284 |
Involvement of glutamate, oxidative stress and inducible nitric oxide synthase in the convulsant activity of ciprofloxacin in mice. |
2012 |
| 285 |
Involvement of glutamate, oxidative stress and inducible nitric oxide synthase in the convulsant activity of ciprofloxacin in mice. |
2012 |
| 286 |
Involvement of glutamate, oxidative stress and inducible nitric oxide synthase in the convulsant activity of ciprofloxacin in mice. |
2012 |
| 287 |
Involvement of glutamate, oxidative stress and inducible nitric oxide synthase in the convulsant activity of ciprofloxacin in mice. |
2012 |
| 288 |
Is PTP1B involved in the protective effect of tungstate on transplanted islets grafts? |
2012 |
| 289 |
Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients. Journal of Clinical Pharmacy and Therapeutics, 2012, 37, 352–355 |
2012 |
| 290 |
Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients. Journal of Clinical Pharmacy and Therapeutics, 2012, 37, 352–355 |
2012 |
هل لديك سؤال ؟
